Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Context Therapeutics Inc Is A Clinical-Stage Biopharmaceutical Company Advancing Medicines For Solid Tumors. The Development Team Is Advancing A Pipeline Of Various Therapies With A Primary Focus On Treating Female, Hormone-Dependent Cancer, Including Breast, Ovarian, And Endometrial Cancer. The Company'S Preclinical Program, Ctim-76, Is An Anti-Claudin 6 (Cldn6) X Anti-Cd3 Bispecific Antibody (Bsab) That Is Intended To Redirect T-Cell-Mediated Lysis Toward Malignant Cells Expressing Cldn6.